• You are here:  
  • Home
  • News
×

Error

Advanced Module Manager cannot function. Regular Labs Library plugin is not installed.
Advanced Template Manager cannot function. Regular Labs Library plugin is not installed.
Better Preview cannot function. Regular Labs Library plugin is not installed.
Articles Anywhere cannot function. Regular Labs Library plugin is not installed.
Better Trash cannot function. Regular Labs Library plugin is not installed.
Cache Cleaner cannot function. Regular Labs Library plugin is not installed.
CDN for Joomla! cannot function. Regular Labs Library plugin is not installed.
Components Anywhere cannot function. Regular Labs Library plugin is not installed.
Conditional Content cannot function. Regular Labs Library plugin is not installed.
Content Templater cannot function. Regular Labs Library plugin is not installed.
Dummy Content cannot function. Regular Labs Library plugin is not installed.
Email Protector cannot function. Regular Labs Library plugin is not installed.
IP Login cannot function. Regular Labs Library plugin is not installed.
Keyboard Shortcuts cannot function. Regular Labs Library plugin is not installed.
Modals cannot function. Regular Labs Library plugin is not installed.
Modules Anywhere cannot function. Regular Labs Library plugin is not installed.
Quick Index cannot function. Regular Labs Library plugin is not installed.
ReReplacer cannot function. Regular Labs Library plugin is not installed.
Simple User Notes cannot function. Regular Labs Library plugin is not installed.
Sliders cannot function. Regular Labs Library plugin is not installed.
Snippets cannot function. Regular Labs Library plugin is not installed.
Sourcerer cannot function. Regular Labs Library plugin is not installed.
Tabs cannot function. Regular Labs Library plugin is not installed.
Tooltips cannot function. Regular Labs Library plugin is not installed.

News

Details
Category: POZ.com
The European Medicines Agency gave the green light to injectable cabotegravir and rilpivirine for HIV treatment.

Read more

Details
Category: POZ.com
If the asylum ban goes forward, “the U.S. will deport countless LGBTQ and HIV-positive refugees back to persecution, torture and death.”

Read more

Details
Category: POZ.com
If the asylum ban goes forward, “the U.S. will deport countless LGBTQ and HIV-positive refugees back to persecution, torture and death.”

Read more

Details
Category: POZ.com
This finding comes from a small focus group of mothers living with HIV in Canada, most of them born in low-income nations.

Read more

Details
Category: POZ.com
This finding among sub-Saharan Africans is quite concerning since dolutegravir is now the preferred first-line HIV treatment worldwide.

Read more

Details
Category: POZ.com
ViiV Healthcare teams with stock photography provider Shutterstock to offer a stigma-busting gallery of images.

Read more

Details
Category: POZ.com
The vaccine, which is safe, was designed using bits of an HIV protein.

Read more

Details
Category: POZ.com
Here are the researchers who will lead the four networks of HIV trials and what each network will focus on.

Read more

Details
Category: POZ.com
The 90-90-90 HIV targets expire at the end of 2020. Bob Leahy looks at what comes next and what role people living with HIV can play.

Read more

Details
Category: POZ.com
While receiving a lifetime achievement award, the infectious disease expert shares memories and insights.

Read more

Details
Category: POZ.com
Plus: Seven European cities surpass the Fast-Track HIV targets.

Read more

Details
Category: POZ.com
UNAIDS hopes nations will follow the lead of a number of sub-Saharan African countries that are gaining control of their HIV epidemics.

Read more

Subcategories

Fundraisers Article Count:  2

Health Article Count:  4

HIV / AIDS Article Count:  4

Partners Article Count:  414

POZ.com Article Count:  413

POZ Stories Article Count:  62

  • You are here:  
  • Home
  • News